{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:47:41Z","timestamp":1790228861679,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejps.2015.06.013","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T03:00:21Z","timestamp":1434423621000},"page":"279-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Topical therapies for skin cancer and actinic keratosis"],"prefix":"10.1016","volume":"77","author":[{"given":"Tasnuva","family":"Haque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khondaker M.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Thurston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hadgraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majella E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.06.013_b0005","series-title":"Kaposi\u2019s Sarcoma","first-page":"71","article-title":"Histologic features of Kaposi\u2019s sarcoma and simulators of it","author":"Ackerman","year":"1985"},{"key":"10.1016\/j.ejps.2015.06.013_b0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0190-9622(94)70054-0","article-title":"Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses","volume":"30","author":"Alirezai","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi\u2019s sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2015.06.013_b0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1023\/A:1015859320604","article-title":"Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines","volume":"7","author":"Aungst","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2015.06.013_b0550","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/pcmr.12333","article-title":"Genetics of familial melanoma: 20 years after CDKN2A","volume":"28","author":"Aoude","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.ejps.2015.06.013_b0025","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2015.06.013_b0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clindermatol.2011.08.007","article-title":"Structure and function of the epidermis related to barrier properties","volume":"30","author":"Baroni","year":"2012","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0035","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11912-013-0342-4","article-title":"Sun exposure, sunbeds and sunscreens and melanoma. What are the controversies?","volume":"15","author":"Bataille","year":"2013","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ejps.2015.06.013_b0040","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.22952","article-title":"Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study","volume":"121","author":"Bath-Hextall","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2015.06.013_b0045","series-title":"Topical and Transdermal Drug Delivery: Principles and Practice","first-page":"3","article-title":"Skin structure, function, and permeation","author":"Benson","year":"2012"},{"key":"10.1016\/j.ejps.2015.06.013_b0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.1987.tb05876.x","article-title":"Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5-fluorouracil: a double-blind controlled study","volume":"116","author":"Bercovitch","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(88)90140-8","article-title":"Damaging effect of acetone on the permeability barrier of hairless mouse skin compared with human skin","volume":"41","author":"Bond","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/carcin\/19.5.723","article-title":"COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer","volume":"19","author":"Buckman","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejps.2015.06.013_b0065","first-page":"10","article-title":"Skin cancer in individuals of African, Asian, Latin\u2013American, and American\u2013Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians","volume":"6","author":"Byrd-Miles","year":"2007","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1517\/13543784.17.3.437","article-title":"Alitretinoin: a comprehensive review","volume":"17","author":"Cheng","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejps.2015.06.013_b0545","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10837459908984222","article-title":"Development of a topically active imiquimod formulation","volume":"4","author":"Chollet","year":"1999","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2015.06.013_b0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/dsu.12464","article-title":"Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion","volume":"40","author":"Christensen","year":"2014","journal-title":"Dermatol. Surg."},{"issue":"1, Part 2","key":"10.1016\/j.ejps.2015.06.013_b0080","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma (\u201cactinic keratosis\u201d)","volume":"42","author":"Cockerell","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijpharm.2006.01.033","article-title":"Enhancing effect of alpha-hydroxyacids on \u201cin vitro\u201d permeation across the human skin of compounds with different lipophilicity","volume":"314","author":"Copov\u00ed","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0090","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejps.2015.06.013_b0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","article-title":"Guidelines for the management of actinic keratoses","volume":"156","author":"de Berker","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0100","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/bmc.1075","article-title":"Development and validation of HPLC method for imiquimod determination in skin penetration studies","volume":"22","author":"De Paula","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejps.2015.06.013_b0525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archderm.1963.01590210005001","article-title":"Selective cytotoxic effect of topical 5-fluorouracil","volume":"88","author":"Dillaha","year":"1963","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archderm.1965.01600160066015","article-title":"Further studies with topical 5-fluorouracil","volume":"92","author":"Dillaha","year":"1965","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2005.10.023","article-title":"Design and physicochemical characterisation of a bioadhesive patch for dose-controlled topical delivery of imiquimod","volume":"307","author":"Donnelly","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ddr.430130203","article-title":"Structure and function of the stratum corneum permeability barrier","volume":"13","author":"Elias","year":"1988","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejps.2015.06.013_b0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archderm.1981.01650030038018","article-title":"Retinoids, cancer and the skin","volume":"117","author":"Elias","year":"1981","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/1523-1747.ep12526137","article-title":"Percutaneous transport in relation to stratum corneum structure and lipid composition","volume":"76","author":"Elias","year":"1981","journal-title":"J. Invest. Dermatol."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2015.06.013_b0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000252588","article-title":"Cutaneous absorption and urinary excretion of 6-14C-5-fluorouracil ointment applicated in an ointment to healthy and diseased human skin","volume":"140","author":"Erlanger","year":"1970","journal-title":"Dermatologica"},{"key":"10.1016\/j.ejps.2015.06.013_b0135","doi-asserted-by":"crossref","unstructured":"Erlendsson, A.M., Taudorf, E.H., Eriksson, A.H., Haak, C.S., Zibert, J.R., Paasch, U., Anderson, R.R., Haedersdal, M., 2015. Ablative fractional laser alters biodistribution of ingenol mebutate in the skin. Arch. Dermatol. Res. In Press. http:\/\/dx.doi.org\/10.1007\/s00403-015-1561-3.","DOI":"10.1007\/s00403-015-1561-3"},{"key":"10.1016\/j.ejps.2015.06.013_b0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2133.1962.tb13497.x","article-title":"Skin changes in patients treated with 5-fluorouracil","volume":"74","author":"Falkson","year":"1962","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0145","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/jid.2010.40","article-title":"Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac\/hyaluronic acid correlates with downregulation of c-FLIP","volume":"130","author":"Fecker","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0150","first-page":"1099","article-title":"The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma","volume":"33","author":"Fuchs","year":"2007","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.ejps.2015.06.013_b0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(97)00123-3","article-title":"Mechanism of transdermal transport of 5-fluorouracil by terpenes: carvone, 1,8-cineole and thymol","volume":"154","author":"Gao","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(97)00430-4","article-title":"Effect of oleic acid\/ethanol and oleic acid\/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis","volume":"165","author":"Gao","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0165","unstructured":"Glaxo Smith Kline, Inc., 2013. Alitretinoin. Product Monograph. pp. 1\u201336."},{"key":"10.1016\/j.ejps.2015.06.013_b0170","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijpharm.2014.07.052","article-title":"Formulation of diclofenac for dermal delivery","volume":"473","author":"Goh","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0175","series-title":"Managing Skin Cancer","first-page":"17","article-title":"Histopathology of skin cancer","author":"Goldenberg","year":"2010"},{"key":"10.1016\/j.ejps.2015.06.013_b0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/1523-1747.ep12475655","article-title":"Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique","volume":"91","author":"Goodman","year":"1988","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0185","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","first-page":"127","article-title":"Biology of melanocytes","author":"Halaban","year":"2003"},{"key":"10.1016\/j.ejps.2015.06.013_b0515","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/path.4259","article-title":"New drug targets in metastatic melanoma","volume":"232","author":"Homet","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejps.2015.06.013_b0190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/jphp.12194","article-title":"Natural polymer-stabilized multiple water-in-oil-in-water emulsions: a novel dermal drug delivery system for 5-fluorouracil","volume":"66","author":"Hoppel","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2015.06.013_b0195","unstructured":"http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm381451.htm."},{"key":"10.1016\/j.ejps.2015.06.013_b0200","first-page":"43","article-title":"Actinic keratoses: a comprehensive update","volume":"2","author":"Ibrahim","year":"2009","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1600-0749.2003.00072.x","article-title":"Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review","volume":"16","author":"Ito","year":"2003","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.ejps.2015.06.013_b0210","first-page":"357","article-title":"Early detection and treatment of skin cancer","volume":"62","author":"Jerant","year":"2000","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.ejps.2015.06.013_b0215","first-page":"2006","article-title":"Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil","volume":"5","author":"Johnson","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2015.06.013_b0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1067\/mjd.2003.451","article-title":"Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial","volume":"49","author":"Kang","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0505","series-title":"Handbook of Experimental Pharmacology","first-page":"103","article-title":"Absorption of drugs through the skin","author":"Katz","year":"1971"},{"key":"10.1016\/j.ejps.2015.06.013_b0225","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3403","article-title":"Characterization of the interaction of ingenol 3-angelate with protein kinase C","volume":"64","author":"Kedei","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2015.06.013_b0230","series-title":"Retinoids in Cutaneous Malignancy","first-page":"66","article-title":"Topical therapy of actinic keratoses with tretinoin","author":"Kligman","year":"1991"},{"key":"10.1016\/j.ejps.2015.06.013_b0235","series-title":"Handbook of Cancer Chemotherapy","first-page":"277","article-title":"Melanomas and other cutaneous malignancies","author":"Kudchadkar","year":"2011"},{"key":"10.1016\/j.ejps.2015.06.013_b0240","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0245","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2011.03.015","article-title":"Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules","volume":"153","author":"Lee","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.06.013_b0250","unstructured":"Leo Pharma, Inc., 2013, Picato. Product Monograph. pp. 1\u201326."},{"key":"10.1016\/j.ejps.2015.06.013_b0255","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0149-2918(01)80077-1","article-title":"A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation","volume":"23","author":"Levy","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2015.06.013_b0260","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0149-2918(01)80078-3","article-title":"A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis","volume":"23","author":"Levy","year":"2001","journal-title":"Clin. Ther."},{"issue":"747","key":"10.1016\/j.ejps.2015.06.013_b0265","first-page":"750","article-title":"Propylene glycol gel vehicles","volume":"23","author":"Lorenzetti","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.ejps.2015.06.013_b0270","doi-asserted-by":"crossref","first-page":"e35309","DOI":"10.1371\/journal.pone.0035309","article-title":"Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials","volume":"7","author":"Lovly","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2015.06.013_b0275","series-title":"Non-Surgical Treatment of Keratinocyte","first-page":"39","article-title":"Environmental risk factors for non-melanoma skin cancers","author":"Madan","year":"2009"},{"key":"10.1016\/j.ejps.2015.06.013_b0280","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1751-1097.2007.00283.x","article-title":"Role of UV in cutaneous melanoma","volume":"84","author":"Maddodi","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejps.2015.06.013_b0285","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0025-6196(11)61033-1","article-title":"Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis","volume":"82","author":"Markovic","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejps.2015.06.013_b0290","first-page":"600","article-title":"Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety","volume":"11","author":"Martin","year":"2012","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0295","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2340\/00015555-2035","article-title":"Metastatic melanoma \u2013 a review of current and future treatment options","volume":"95","author":"Maverakis","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ejps.2015.06.013_b0300","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archderm.1997.03890410049006","article-title":"Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes","volume":"133","author":"McCormack","year":"1997","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.02.007","article-title":"Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs","volume":"180","author":"McCrudden","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.06.013_b0310","series-title":"Rook\u2019s Textbook of Dermatology","first-page":"45","article-title":"Anatomy and organization of human skin","author":"McGrath","year":"2008"},{"key":"10.1016\/j.ejps.2015.06.013_b0315","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjoto.2008.03.002","article-title":"Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior","volume":"30","author":"McGuire","year":"2009","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.ejps.2015.06.013_b0495","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.06.005","article-title":"The structure and function of the stratum corneum","volume":"435","author":"Menon","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"Suppl 5","key":"10.1016\/j.ejps.2015.06.013_b0320","doi-asserted-by":"crossref","first-page":"112S","DOI":"10.1038\/jid.1994.20","article-title":"Genetics of cutaneous melanoma","volume":"103","author":"Meyer","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0520","unstructured":"MHRA, 2010. Public assessment report. Repeat use mutual recognition procedure. SolarazeTM 3% gel. Medicines and Healthcare Products Regulatory Agency. United Kingdom. pp. 1\u201338."},{"key":"10.1016\/j.ejps.2015.06.013_b0325","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/aic.690210522","article-title":"Drug permeation through human skin: theory and in vitro experimental measurement","volume":"21","author":"Michaels","year":"1975","journal-title":"AIChE J."},{"issue":"Suppl. 52","key":"10.1016\/j.ejps.2015.06.013_b0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.1998.1390s2003.x","article-title":"Pharmacology of adapalene","volume":"139","author":"Michel","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0335","series-title":"Clarke\u2019s Analysis of Drugs and Poisons, fourth ed.","year":"2011"},{"key":"10.1016\/j.ejps.2015.06.013_b0340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0378-5173(82)90115-6","article-title":"Pro-drugs as drug delivery systems XXIII. Improved dermal delivery of 5-fluorouracil through human skin via N-acyloxymethyl pro-drug derivatives","volume":"12","author":"Mollgaard","year":"1982","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0345","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.0007-0963.2001.04615.x","article-title":"Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma","volume":"146","author":"Motley","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0350","series-title":"Non-Surgical Treatment of Keratinocyte Skin Cancer","first-page":"1","article-title":"From precursor to cancer: field cancerization and the opportunities for therapy","author":"Murphy","year":"2009"},{"key":"10.1016\/j.ejps.2015.06.013_b0355","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10717544.2013.845861","article-title":"Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers","volume":"21","author":"Mutalik","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2015.06.013_b0360","series-title":"The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals","year":"2013"},{"key":"10.1016\/j.ejps.2015.06.013_b0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1068-607X(98)00034-1","article-title":"Percutaneous penetration of Aldara cream, 5% during the topical treatment of genital and perianal warts","volume":"5","author":"Owens","year":"1998","journal-title":"Prim. Care Update Ob. Gyns."},{"key":"10.1016\/j.ejps.2015.06.013_b0370","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00018-009-8703-8","article-title":"Cellular mechanisms regulating human melanogenesis","volume":"66","author":"Park","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejps.2015.06.013_b0375","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/09546634.2012.735641","article-title":"Another approach to actinic keratosis management using nonablative fractional laser","volume":"25","author":"Pearce","year":"2014","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.ejps.2015.06.013_b0500","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/1523-1747.ep12470197","article-title":"The influence of stratum corneum morphology on water permeability","volume":"96","author":"Potts","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0380","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/09546634.2012.687088","article-title":"Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities","volume":"24","author":"Prens","year":"2013","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.ejps.2015.06.013_b0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1034\/j.1600-0854.2002.030401.x","article-title":"The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis","volume":"3","author":"Raposo","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.ejps.2015.06.013_b0390","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1067\/mjd.2001.112361","article-title":"UV-specific p53 and PTCH mutations in sporadic basal cell carcinoma of sun-exposed skin","volume":"44","author":"Ratner","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0395","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I","article-title":"The annual report to the nation on the status of cancer, 1973\u20131997, with a special section on colorectal cancer","volume":"88","author":"Ries","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejps.2015.06.013_b0400","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archderm.1997.03890460061007","article-title":"An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses","volume":"133","author":"Rivers","year":"1997","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0405","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","article-title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response","volume":"66","author":"Rosen","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl. 3","key":"10.1016\/j.ejps.2015.06.013_b0410","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","article-title":"Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification","volume":"156","author":"R\u00f6wert-Huber","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"Suppl 2","key":"10.1016\/j.ejps.2015.06.013_b0540","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.08265.x","article-title":"Imiquimod: mode of action","volume":"157","author":"Sch\u00f6n","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"2 Pt 2","key":"10.1016\/j.ejps.2015.06.013_b0415","first-page":"326","article-title":"Keratoacanthoma: a clinico-pathologic enigma","volume":"30","author":"Schwartz","year":"2004","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.ejps.2015.06.013_b0535","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2133.1988.tb02436.x","article-title":"Topical 5-fluorouracil solution in the treatment of warts-clinical experience and percutaneous absorption","volume":"118","author":"Senff","year":"1988","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0420","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-0960.2008.00497.x","article-title":"PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study","volume":"50","author":"Siller","year":"2009","journal-title":"Aust. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0425","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2005.04.004","article-title":"Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum","volume":"298","author":"Singh","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"4 Suppl","key":"10.1016\/j.ejps.2015.06.013_b0430","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.12788\/j.sder.0100","article-title":"New therapeutic options for actinic keratosis and basal cell carcinoma","volume":"33","author":"Sligh","year":"2014","journal-title":"Semin Cutan. Med. Surg."},{"key":"10.1016\/j.ejps.2015.06.013_b0435","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(98)00187-4","article-title":"Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations","volume":"59","author":"Suhonen","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2015.06.013_b0440","first-page":"247","article-title":"Topical administration of anticancer drugs for skin cancer treatment in skin cancers \u2013 risk factors, prevention and therapy","author":"Taveira","year":"2011"},{"key":"10.1016\/j.ejps.2015.06.013_b0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.2008.08666.x","article-title":"Guidelines for the management of basal cell carcinoma","volume":"159","author":"Telfer","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0450","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijpharm.2008.05.034","article-title":"Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil","volume":"361","author":"Venuganti","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0530","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/jps.21603","article-title":"Poly(amidoamine) dendrimers as skin penetration enhancers: influence of charge, generation, and concentration","volume":"98","author":"Venuganti","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.06.013_b0455","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2012.04.024","article-title":"The human nail \u2013 barrier characterisation and permeation enhancement","volume":"435","author":"Walters","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.06.013_b0460","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0465","doi-asserted-by":"crossref","first-page":"e41501","DOI":"10.1371\/journal.pone.0041501","article-title":"Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine","volume":"7","author":"Weldon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2015.06.013_b0470","series-title":"Transdermal Drug Delivery: Developmental Issue and Research Initiatives","first-page":"1","article-title":"Stratum corneum: biological and biochemical considerations","author":"Wertz","year":"1989"},{"key":"10.1016\/j.ejps.2015.06.013_b0475","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ics.12001","article-title":"Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery","volume":"34","author":"Wiechers","year":"2012","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ejps.2015.06.013_b0480","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000366548","article-title":"Update on photodynamic treatment for actinic keratosis","volume":"46","author":"Wiegell","year":"2015","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.ejps.2015.06.013_b0485","series-title":"The human skin. Studies on Biology, vol. 164","author":"Wood","year":"1985"},{"key":"10.1016\/j.ejps.2015.06.013_b0490","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clindermatol.2013.05.028","article-title":"Morphologic grading and treatment of facial actinic keratosis","volume":"32","author":"Zalaudek","year":"2014","journal-title":"Clin. Dermatol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715003085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715003085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T15:25:51Z","timestamp":1537543551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715003085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":109,"alternative-id":["S0928098715003085"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.06.013","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical therapies for skin cancer and actinic keratosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}